These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1631501)

  • 41. Serum dihydrotestosterone in patients with benign prostatic hypertrophy.
    Ghanadian R; Lewis JG; Chisholm GD; O'Donoghue EP
    Br J Urol; 1977 Nov; 49(6):541-4. PubMed ID: 73397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy.
    Geller J; Albert JD; Nachtsheim DA; Loza D
    J Urol; 1984 Oct; 132(4):693-6. PubMed ID: 6471215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels.
    Meikle AW; Smith JA; West DW
    Prostate; 1985; 6(2):121-8. PubMed ID: 3975174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low serum testosterone/dihydrotestosterone ratio in patients with pancreatic carcinoma.
    Robles-Diaz G; Diaz-Sanchez V; Mendez JP; Altamirano A; Wolpert E
    Pancreas; 1987; 2(6):684-7. PubMed ID: 3438305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.
    Addo SB; Holland JF; Kirschenbaum A; Mandeli J; Hollander VP
    Steroids; 1990 Nov; 55(11):491-4. PubMed ID: 1706116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of testosterone, sex hormone binding globulin, and calculated free testosterone to subsequent clinical progress in patients with carcinoma of the prostate treated with bilateral orchidectomy or estrogens.
    Levell MJ; Siddall JK; Rowe E; Glashan RW; Robinson MR; Pidcock NB
    Prostate; 1987; 11(1):17-21. PubMed ID: 3658825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma testosterone and dihydrotestosterone in male rats during sexual maturation and following orchidectomy and experimental bilateral cryptorchidism.
    Gupta D; Zarzycki J; Rager K
    Steroids; 1975 Jan; 25(1):33-42. PubMed ID: 234199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
    Ponder BA; Shearer RJ; Pocock RD; Miller J; Easton D; Chilvers CE; Dowsett M; Jeffcoate SL
    Br J Cancer; 1984 Dec; 50(6):757-63. PubMed ID: 6238616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum testosterone and dihydrotestosterone levels following orchiectomy in the adult rat.
    Coyotupa J; Parlow AF; Kovacic N
    Endocrinology; 1973 Jun; 92(6):1579-81. PubMed ID: 4707253
    [No Abstract]   [Full Text] [Related]  

  • 50. Urate calculi complicating orchidectomy in a patient with advanced prostatic cancer. Case report.
    Roosen JU; Rungby JA; Hvidt V
    Scand J Urol Nephrol; 1991; 25(1):81-2. PubMed ID: 2047778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.
    Dowsett M; Shearer RJ; Ponder BA; Malone P; Jeffcoate SL
    Br J Cancer; 1988 Feb; 57(2):190-2. PubMed ID: 3358910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppressive effects of surgical stress on circulating androgens during and after prostatectomy.
    Ghanadian R; Puah CM; Williams G; Shah PJ; McWhinney N
    Br J Urol; 1981 Apr; 53(2):147-9. PubMed ID: 6165423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The determination in human males of specific testosterone and 5aplha-dihydrotestosterone binding to sex hormone binding globulin by a differential dissociation technique.
    Horst HJ; Becker H; Voigt KD
    Steroids; 1974 Jun; 23(6):833-44. PubMed ID: 4134523
    [No Abstract]   [Full Text] [Related]  

  • 54. Regarding Zagars and Pollack.
    Daniell HW
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):973-4. PubMed ID: 9652869
    [No Abstract]   [Full Text] [Related]  

  • 55. CO2 laser subcapsular orchidectomy in the treatment of metastatic prostate cancer.
    Bolton DM; Costello AJ
    Lasers Surg Med; 1994; 14(1):88-9. PubMed ID: 8127213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Hormones, elderly testes, and carcinoma of the prostate.
    Habib FK; Stitch SR
    Br Med J; 1975 Dec; 4(5997):650. PubMed ID: 54202
    [No Abstract]   [Full Text] [Related]  

  • 57. A systematic review of methods for quantifying serum testosterone in patients with prostate cancer who underwent castration.
    Comas I; Ferrer R; Planas J; Celma A; Regis L; Morote J
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):86-93. PubMed ID: 28259362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low serum testosterone concentrations in patients with carcinoma of the pancreas.
    Greenway B; Iqbal MJ; Johnson PJ; Williams R
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):93-5. PubMed ID: 6401508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salivary testosterone in prostatic carcinoma.
    Navarro MA; Aguiló F; Villabona CM; Torrecilla C; Bonnin R
    Br J Urol; 1989 Mar; 63(3):306-8. PubMed ID: 2702429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen.
    Henriksson P; Carlström K; Pousette A; Gunnarsson PO; Johansson CJ; Eriksson B; Altersgård-Brorsson AK; Nordle O; Stege R
    Prostate; 1999 Jul; 40(2):76-82. PubMed ID: 10386467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.